Correlation of molecular genetic analysis of p53, MDM2, p16, PTEN, and EGFR and survival of patients with anaplastic astrocytoma and glioblastoma

Yukitaka Ushio, Kenji Tada, Shoji Shiraishi, Takanori Kamiryo, Naoki Shinojima, Masato Kochi, Hideyuki Saya

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

This article reviews studies on the correlation between genetic abnormalities in malignant astrocytic tumors and patient survival. It is almost certain that alterations of PTEN on chromosome 10 represent a significant unfavorable prognostic factor in glioblastoma patients. The association of alterations in p53, MDM2, p16 or EGFR with the survival of patients with anaplastic astrocytoma or glioblastoma remains controversial. It is possible that the p16 alteration and EGFR amplification are associated with poor survival in certain groups of patients and that there might be a relationship with age. Malignant transformation of astrocytic cells are driven by the sequential acquisition of genetic alteration. Therefore, it is reasonable to subgroup gliomas by their patterns of genetic alterations. However the studies that correlated the multiple genetic alterations with survival are still limitted. Further studies on large cohorts are necessary to elucidate the genetic factors that affect the prognosis and response to therapy of patients with malignant gliomas and to develop effective management strategies.

Original languageEnglish
JournalFrontiers in Bioscience
Volume8
Publication statusPublished - 2003
Externally publishedYes

Fingerprint

Astrocytoma
Glioblastoma
Chromosomes
Amplification
Tumors
Molecular Biology
Cells
Survival
Glioma
Chromosomes, Human, Pair 10
Neoplasms

Keywords

  • Anaplastic Astrocytoma
  • EGFR
  • Glioblastoma
  • MDM2
  • p16
  • p53
  • PTEN
  • Review
  • Survival

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry
  • Cell Biology

Cite this

Correlation of molecular genetic analysis of p53, MDM2, p16, PTEN, and EGFR and survival of patients with anaplastic astrocytoma and glioblastoma. / Ushio, Yukitaka; Tada, Kenji; Shiraishi, Shoji; Kamiryo, Takanori; Shinojima, Naoki; Kochi, Masato; Saya, Hideyuki.

In: Frontiers in Bioscience, Vol. 8, 2003.

Research output: Contribution to journalArticle

Ushio, Yukitaka ; Tada, Kenji ; Shiraishi, Shoji ; Kamiryo, Takanori ; Shinojima, Naoki ; Kochi, Masato ; Saya, Hideyuki. / Correlation of molecular genetic analysis of p53, MDM2, p16, PTEN, and EGFR and survival of patients with anaplastic astrocytoma and glioblastoma. In: Frontiers in Bioscience. 2003 ; Vol. 8.
@article{007ede678c6844c4a97fa53dda134b30,
title = "Correlation of molecular genetic analysis of p53, MDM2, p16, PTEN, and EGFR and survival of patients with anaplastic astrocytoma and glioblastoma",
abstract = "This article reviews studies on the correlation between genetic abnormalities in malignant astrocytic tumors and patient survival. It is almost certain that alterations of PTEN on chromosome 10 represent a significant unfavorable prognostic factor in glioblastoma patients. The association of alterations in p53, MDM2, p16 or EGFR with the survival of patients with anaplastic astrocytoma or glioblastoma remains controversial. It is possible that the p16 alteration and EGFR amplification are associated with poor survival in certain groups of patients and that there might be a relationship with age. Malignant transformation of astrocytic cells are driven by the sequential acquisition of genetic alteration. Therefore, it is reasonable to subgroup gliomas by their patterns of genetic alterations. However the studies that correlated the multiple genetic alterations with survival are still limitted. Further studies on large cohorts are necessary to elucidate the genetic factors that affect the prognosis and response to therapy of patients with malignant gliomas and to develop effective management strategies.",
keywords = "Anaplastic Astrocytoma, EGFR, Glioblastoma, MDM2, p16, p53, PTEN, Review, Survival",
author = "Yukitaka Ushio and Kenji Tada and Shoji Shiraishi and Takanori Kamiryo and Naoki Shinojima and Masato Kochi and Hideyuki Saya",
year = "2003",
language = "English",
volume = "8",
journal = "Frontiers in Bioscience - Landmark",
issn = "1093-9946",
publisher = "Frontiers in Bioscience",

}

TY - JOUR

T1 - Correlation of molecular genetic analysis of p53, MDM2, p16, PTEN, and EGFR and survival of patients with anaplastic astrocytoma and glioblastoma

AU - Ushio, Yukitaka

AU - Tada, Kenji

AU - Shiraishi, Shoji

AU - Kamiryo, Takanori

AU - Shinojima, Naoki

AU - Kochi, Masato

AU - Saya, Hideyuki

PY - 2003

Y1 - 2003

N2 - This article reviews studies on the correlation between genetic abnormalities in malignant astrocytic tumors and patient survival. It is almost certain that alterations of PTEN on chromosome 10 represent a significant unfavorable prognostic factor in glioblastoma patients. The association of alterations in p53, MDM2, p16 or EGFR with the survival of patients with anaplastic astrocytoma or glioblastoma remains controversial. It is possible that the p16 alteration and EGFR amplification are associated with poor survival in certain groups of patients and that there might be a relationship with age. Malignant transformation of astrocytic cells are driven by the sequential acquisition of genetic alteration. Therefore, it is reasonable to subgroup gliomas by their patterns of genetic alterations. However the studies that correlated the multiple genetic alterations with survival are still limitted. Further studies on large cohorts are necessary to elucidate the genetic factors that affect the prognosis and response to therapy of patients with malignant gliomas and to develop effective management strategies.

AB - This article reviews studies on the correlation between genetic abnormalities in malignant astrocytic tumors and patient survival. It is almost certain that alterations of PTEN on chromosome 10 represent a significant unfavorable prognostic factor in glioblastoma patients. The association of alterations in p53, MDM2, p16 or EGFR with the survival of patients with anaplastic astrocytoma or glioblastoma remains controversial. It is possible that the p16 alteration and EGFR amplification are associated with poor survival in certain groups of patients and that there might be a relationship with age. Malignant transformation of astrocytic cells are driven by the sequential acquisition of genetic alteration. Therefore, it is reasonable to subgroup gliomas by their patterns of genetic alterations. However the studies that correlated the multiple genetic alterations with survival are still limitted. Further studies on large cohorts are necessary to elucidate the genetic factors that affect the prognosis and response to therapy of patients with malignant gliomas and to develop effective management strategies.

KW - Anaplastic Astrocytoma

KW - EGFR

KW - Glioblastoma

KW - MDM2

KW - p16

KW - p53

KW - PTEN

KW - Review

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=3142658180&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3142658180&partnerID=8YFLogxK

M3 - Article

VL - 8

JO - Frontiers in Bioscience - Landmark

JF - Frontiers in Bioscience - Landmark

SN - 1093-9946

ER -